Jazz Pharmaceuticals(JAZZ) Prnewswire·2025-02-11 21:15Core Viewpoint - Jazz Pharmaceuticals plc will report its 2024 full year and fourth quarter financial results on February 25, 2025, after U.S. market close, followed by a live audio webcast to discuss the results and provide updates [1]. Group 1: Financial Results Announcement - The financial results for the full year and fourth quarter of 2024 will be announced on February 25, 2025 [1]. - A live audio webcast will take place at 4:30 p.m. ET / 9:30 p.m. GMT to discuss the financial results [1]. Group 2: Webcast Access Information - Interested parties can access the live audio webcast via the Investors section of the Jazz Pharmaceuticals website [2]. - It is recommended that participants register at least 15 minutes prior to the scheduled webcast for a timely connection [2]. Group 3: Company Overview - Jazz Pharmaceuticals is a global biopharma company focused on developing life-changing medicines for serious diseases with limited therapeutic options [4]. - The company has a diverse portfolio, including therapies for sleep disorders, epilepsy, and a growing range of cancer treatments [4]. - Jazz is headquartered in Dublin, Ireland, with research and development facilities and employees in multiple countries [4].